{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE SENATE OF THE UNITED STATES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "S. 2126"}, "official-title": {"#tail": "\n\t", "#text": "To launch a national strategy to support regenerative medicine through the establishment of a\n\t\t\t Regenerative Medicine Coordinating Council, and for other purposes."}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "II"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20140313", "#text": "March 13, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "SSHR00", "#text": "Committee on Health, Education, Labor, and Pensions"}, "sponsor": {"#tail": " (for herself and ", "#text": "Mrs. Boxer", "@name-id": "S223"}, "cosponsor": {"#tail": ") introduced the following bill; which was read twice and referred to the ", "#text": "Mr. Kirk", "@name-id": "S339"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-Senate", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "Regenerative Medicine Promotion Act of 2014", "@value": "Regenerative Medicine Promotion Act of 2014", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n\t\t\t", "#text": "1."}, "header": {"#tail": "\n\t\t\t", "#text": "Short title"}, "#text": "\n\t\t\t", "@id": "HF4A701B135994F54882BB21B3C4D6546"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " finds the following:", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, "#text": "\n        ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n\t\t\t", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Findings"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Regenerative medicine has the potential to\n\t\t\t treat many chronic diseases, promote economic growth, and reduce health\n\t\t\t care\n\t\t\t spending in the United States.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n\t\t\t\t", "#text": "(1)"}, "@id": "H4E4B41426414474AA3F5C7D42B310FB2", "#text": "\n\t\t\t\t"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Regenerative\n\t\t\t medicine products have already successfully treated numerous health\n\t\t\t conditions\n\t\t\t and have the potential to provide cures, treatments and diagnostics for a\n\t\t\t range\n\t\t\t of diseases and disabilities including diabetes, spinal cord injury, heart\n\t\t\t disease, stroke, various forms of cancer, and other age-related conditions\n\t\t\t that\n\t\t\t represent a huge quality of life, social, and economic burden on\n\t\t\t society."}, "enum": {"#tail": "\n\t\t\t\t", "#text": "(2)"}, "@id": "HBE5F35F666F34E4D9A3B91FB9280FD53", "#text": "\n\t\t\t\t"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "A United States\n\t\t\t national strategy on regenerative medicine is critical to ensure that this\n\t\t\t technology fulfills its potential to cure and treat diseases and\n\t\t\t disabilities,\n\t\t\t reduce overall health care spending, and promote economic growth."}, "enum": {"#tail": "\n\t\t\t\t", "#text": "(3)"}, "@id": "ID8d95207e28264cc69bb7071c0968b0dc", "#text": "\n\t\t\t\t"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " has stated that regenerative medicine has the potential to treat\n\t\t\t many\n\t\t\t battlefield injuries such as burns, that it has the potential to heal\n\t\t\t wounds\n\t\t\t without scarring, and that it has the potential to be used for\n\t\t\t craniofacial\n\t\t\t reconstruction, limb reconstruction, regeneration, and transplantation.", "@entity-type": "federal-body", "#text": "Department of\n\t\t\t Defense", "@entity-id": "9700"}, "#text": "The "}, "enum": {"#tail": "\n\t\t\t\t", "#text": "(4)"}, "@id": "HFB61ED8F3B874D3F89D111ED3E2DED09", "#text": "\n\t\t\t\t"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t and the Multi-Agency Tissue Engineering Science Interagency Working Group\n\t\t\t have\n\t\t\t endorsed a national initiative to support research and product development\n\t\t\t in\n\t\t\t regenerative medicine.", "@entity-type": "federal-body", "#text": "Department of Health and Human Services", "@entity-id": "7500"}, "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n\t\t\t\t", "#text": "(5)"}, "@id": "H65825A612C814414ADBB179253E3EF4E", "#text": "\n\t\t\t\t"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " has said the potential benefits of regenerative\n\t\t\t medicine in improved health care and economic savings are enormous. States\n\t\t\t that\n\t\t\t have invested in regenerative medicine have experienced economic growth\n\t\t\t and see\n\t\t\t future growth potential, including an increase in biotech employment,\n\t\t\t payroll\n\t\t\t increases, and proportional impacts on tax receipts.", "@entity-type": "federal-body", "#text": "Department of\n\t\t\t Health and Human Services", "@entity-id": "7500"}, "#text": "The "}, "enum": {"#tail": "\n\t\t\t\t", "#text": "(6)"}, "@id": "HDBC13EC5C0914C02AE7BA40AD901C659", "#text": "\n\t\t\t\t"}], "#text": "\n\t\t\t", "@id": "HCC3271438CB7458991F56CBE5BFDB8F2"}, {"@section-type": "subsequent-section", "#tail": "\n    ", "text": {"#tail": "\n    ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall\n\t\t\t provide for the completion, and submission to ", "@entity-type": "federal-body", "#text": "Comptroller General of the United States", "@entity-id": "0500"}, {"#tail": ", of a report\n\t\t\t identifying\n\t\t\t all ongoing Federal programs and activities regarding regenerative\n\t\t\t medicine.", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}], "#text": "Not later than 90 days after the date of the\n\t\t\t enactment of this Act, the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Report on ongoing\n\t\t\t Federal programs and activities regarding regenerative medicine", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n      ", "@id": "H6642FE961E79448CA36C2E9FB0266320", "@commented": "no"}, {"#tail": "\n  ", "enum": {"#tail": "\n\t\t\t", "#text": "4."}, "header": {"#tail": "\n\t\t\t", "#text": "Establishment of\n\t\t\t Regenerative Medicine Coordinating Council"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t shall establish, in the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, {"#tail": ", a ", "@entity-type": "federal-body", "#text": "Office of the Secretary", "@entity-id": "7501"}, {"@proposed": "true", "#tail": " (in this section referred to as the\n\t\t\t ", "@entity-type": "federal-body", "@value": "Regenerative Medicine Coordinating Council", "@entity-parent-id": "750S", "#text": "Regenerative Medicine\n\t\t\t Coordinating Council"}], "quote": {"#tail": ").", "#text": "Council"}, "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n\t\t\t\t", "#text": "(a)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Establishment"}, "#text": "\n\t\t\t\t", "@id": "H43FB6648C5BC44C7BC6E8BA0806CE4CE"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": " shall be composed of the\n\t\t\t following:", "@entity-type": "federal-body", "@value": "Regenerative Medicine Coordinating Council", "@entity-parent-id": "750S", "#text": "Council"}, "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n\t\t\t\t", "#text": "(b)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Composition"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary of\n\t\t\t Commerce", "@entity-id": "1300"}, "#text": "The "}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(1)"}, "@id": "HD47F02D75D104BC98B9DA2CFF4E00104", "#text": "\n\t\t\t\t\t"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary of\n\t\t\t Defense", "@entity-id": "9700"}, "#text": "The "}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(2)"}, "@id": "HC33D6AF6F7A24EE79B83BE693B830337", "#text": "\n\t\t\t\t\t"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary of Health and Human\n\t\t\t Services", "@entity-id": "7500"}, "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(3)"}, "@id": "HF33034AEF0F542D6B131269B2D85902A", "#text": "\n\t\t\t\t\t"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary of\n\t\t\t the Treasury", "@entity-id": "2000"}, "#text": "The "}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(4)"}, "@id": "HC8CA609F0AE74B0799334944F3292908", "#text": "\n\t\t\t\t\t"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary of\n\t\t\t Veterans Affairs", "@entity-id": "3600"}, "#text": "The "}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(5)"}, "@id": "HCBAD42B168744212B8F85CBF47F8D8DC", "#text": "\n\t\t\t\t\t"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Administrator\n\t\t\t of the Agency for Healthcare Research and Quality", "@entity-id": "7528"}, "#text": "The "}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(6)"}, "@id": "H4EFF91418A9043A69CA28BB96F96CB95", "#text": "\n\t\t\t\t\t"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Administrator\n\t\t\t of the Centers for Medicare & Medicaid Services", "@entity-id": "7530"}, "#text": "The "}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(7)"}, "@id": "H3D6AB064DE174AFBB9AC5F806885D771", "#text": "\n\t\t\t\t\t"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Commissioner\n\t\t\t of Food and Drugs", "@entity-id": "7524"}, "#text": "The "}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(8)"}, "@id": "H3F6347B9B042491A8FC205B02F47544F", "#text": "\n\t\t\t\t\t"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Director of the National Institutes of\n\t\t\t Health", "@entity-id": "7529"}, "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(9)"}, "@id": "H31605E69D3E24F79B9A6EB49781F0E83", "#text": "\n\t\t\t\t\t"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Director of the National Institutes of\n\t\t\t Standards and Technology", "@entity-id": "1341"}, "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(10)"}, "@id": "HF88660B2E7A74C57AFB7015D1D42ECE4", "#text": "\n\t\t\t\t\t"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary of Health and Human\n\t\t\t Services", "@entity-id": "7500"}, "#text": "Such other\n\t\t\t members as may be appointed by the "}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(11)"}, "@id": "H8EBD484065DE4BCDAD1583B1AF1DE204", "#text": "\n\t\t\t\t\t"}], "#text": "\n\t\t\t\t", "@id": "HB12DD433B06E40F09CC412D472CAB69A"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t shall be the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, {"@proposed": "true", "#tail": ".", "@entity-type": "federal-body", "@value": "Regenerative Medicine Coordinating Council", "@entity-parent-id": "750S", "#text": "Chair of the Council"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n\t\t\t\t", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Chair"}, "#text": "\n\t\t\t\t", "@id": "H0D6263D3BB154AE287072D8969C1D3E4"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"@proposed": "true", "#tail": " appointed by the ", "@entity-type": "federal-body", "@value": "Regenerative Medicine Coordinating Council", "@entity-parent-id": "750S", "#text": "Council"}, {"#tail": "\n\t\t\t under ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human\n\t\t\t Services", "@entity-id": "7500"}, {"#tail": " shall include health insurers, regenerative\n\t\t\t medicine\n\t\t\t researchers from academic institutions, patient advocates, persons with\n\t\t\t expertise in drug discovery, persons with expertise in drug development,\n\t\t\t persons with expertise in basic research, persons with expertise in\n\t\t\t translational research, persons with expertise in medical device\n\t\t\t development,\n\t\t\t persons with expertise in biomaterials, and persons with expertise in\n\t\t\t clinical\n\t\t\t research.", "@entity-type": "act", "#text": "subsection (b)(11)", "@value": "Regenerative Medicine Promotion Act of 2014/s:4/ss:b/p:11", "@proposed": "true"}], "#text": "The\n\t\t\t members of the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n\t\t\t\t", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Members\n\t\t\t appointed by Secretary"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t", "@id": "H164719FFA34D44B89E8580890D63ABED"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": " shall\u2014", "@entity-type": "federal-body", "@value": "Regenerative Medicine Coordinating Council", "@entity-parent-id": "750S", "#text": "Council"}, "#text": "The\n\t\t\t "}, "enum": {"#tail": "\n\t\t\t\t", "#text": "(e)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Functions"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "prepare, and keep up-to-date, a national\n\t\t\t strategy to support research into regenerative medicine and enable the\n\t\t\t development of drugs, biological products, medical devices, and\n\t\t\t biomaterials\n\t\t\t for use in regenerative medicine;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(1)"}, "@id": "H921482C96CDD4123AB3A80F0E7E3D1BD", "#text": "\n\t\t\t\t\t"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "develop national\n\t\t\t goals for regenerative medicine research and product development;"}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(2)"}, "@id": "id4423DC50A41F4390BB9F0500C52647FC", "#text": "\n\t\t\t\t\t"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "prepare a plan\n\t\t\t specifying priorities for research into regenerative medicine;"}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(3)"}, "@id": "H36177E3C801D45B7B5D33352FE7A1C82", "#text": "\n\t\t\t\t\t"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "identify sources\n\t\t\t of funding for research into regenerative medicine;"}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(4)"}, "@id": "HA467AC10051147CC8B6EA29355FE3208", "#text": "\n\t\t\t\t\t"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "identify areas\n\t\t\t where such funding is inadequate or duplicative;"}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(5)"}, "@id": "HB7EC9E33DB1646058BD61D506EE8527C", "#text": "\n\t\t\t\t\t"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "make recommendations regarding Federal\n\t\t\t regulatory, reimbursement, and other policies that will support\n\t\t\t development and\n\t\t\t marketing of regenerative medicine products;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(6)"}, "@id": "H6741674AEBEC49C89D2133C378F6E7A3", "#text": "\n\t\t\t\t\t"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "develop consensus standards regarding\n\t\t\t scientific issues critical to regulatory approval of regenerative medicine\n\t\t\t products; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(7)"}, "#text": "\n\t\t\t\t\t", "@id": "HDCE4F8B328084B4FA56955B3AC2DF365", "@commented": "no"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "determine the need\n\t\t\t for establishing centers of excellence or consortia to further advance\n\t\t\t regenerative medicine."}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(8)"}, "#text": "\n\t\t\t\t\t", "@id": "H6FA778E1CF6C4DABB9DF1208040185DB", "@commented": "no"}], "#text": "\n\t\t\t\t", "@id": "H7327C1AFCD934CE696A0308473D65686"}, {"#tail": "\n    ", "enum": {"#tail": "\n\t\t\t\t", "#text": "(f)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Transparency;\n\t\t\t reporting requirements"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": " shall adopt procedures to ensure the receipt of public input, such\n\t\t\t as\n\t\t\t holding public stakeholder meetings or creating advisory boards.", "@entity-type": "federal-body", "@value": "Regenerative Medicine Coordinating Council", "@entity-parent-id": "750S", "#text": "Council"}, "#text": "The\n\t\t\t "}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Transparency"}, "#text": "\n\t\t\t\t\t", "@id": "HC0E46F08382A4AC4ACA8266975C32685"}, {"#tail": "\n      ", "@id": "H18425E28A10A4AEE91B1AD94AB1C5AF7", "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Annual\n\t\t\t reports"}, "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"@proposed": "true", "#tail": " shall\n\t\t\t submit an annual report on its activities to ", "@entity-type": "federal-body", "@value": "Regenerative Medicine Coordinating Council", "@entity-parent-id": "750S", "#text": "Council"}, {"#tail": ", the ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": ", and the ", "@entity-type": "federal-body", "#text": "Director of the\n\t\t\t National Institutes of Health", "@entity-id": "7529"}, {"#tail": ".\n\t\t\t Each\n\t\t\t such report shall\u2014", "@entity-type": "federal-body", "#text": "Commissioner of Food and Drugs", "@entity-id": "7524"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "#text": "\n\t\t\t\t\t", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": " for regenerative\n\t\t\t medicine;", "@entity-type": "federal-body", "@value": "Regenerative Medicine Coordinating Council", "@entity-parent-id": "750S", "#text": "Council"}, "#text": "provide details on\n\t\t\t progress in meeting goals identified by the "}, "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(A)"}, "@id": "H61967A40B3E44232A9F4C3C3A2066FEE", "#text": "\n\t\t\t\t\t\t"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": ";", "@entity-type": "federal-body", "@value": "Regenerative Medicine Coordinating Council", "@entity-parent-id": "750S", "#text": "Council"}, "#text": "provide\n\t\t\t recommendations regarding funding, regulatory, or other policies to\n\t\t\t achieve\n\t\t\t regenerative medicine goals identified by the "}, "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(B)"}, "@id": "ID78629c5df251498a837d5c3eaaf9f51e", "#text": "\n\t\t\t\t\t\t"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "identify\n\t\t\t regenerative medicine products currently on the market and those in\n\t\t\t development;"}, "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(C)"}, "@id": "H3EB9ED504FAA4EC99486FAD73A3FCC43", "#text": "\n\t\t\t\t\t\t"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "identify\n\t\t\t regenerative medicine research and technological advances and discoveries\n\t\t\t that\n\t\t\t occurred in the previous year; and"}, "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(D)"}, "@id": "HCEB8A76AABD14F80B2A320AA13D8FE39", "#text": "\n\t\t\t\t\t\t"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "assess the impact\n\t\t\t of regenerative medicine on the Nation's economy, including with respect\n\t\t\t to\u2014"}, "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(E)"}, "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "the\n\t\t\t number of people employed in companies or research institutions working in\n\t\t\t regenerative medicine;"}, "enum": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "(i)"}, "@id": "H26F18AA9DB5E4DAEA07CE399F00418F2", "#text": "\n\t\t\t\t\t\t\t"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "the\n\t\t\t number of companies pursuing regenerative medicine products; and"}, "enum": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "(ii)"}, "@id": "H3D1FF06A54F74BE8BE2B2889A78288E7", "#text": "\n\t\t\t\t\t\t\t"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "increases in tax\n\t\t\t revenues."}, "enum": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "(iii)"}, "@id": "HB7E7FEF2B04E4712A5A5A2E9D66A6A24", "#text": "\n\t\t\t\t\t\t\t"}], "#text": "\n\t\t\t\t\t\t", "@id": "HB2DFED01EAF64A30A4F647C6783AE35F"}]}], "#text": "\n\t\t\t\t", "@id": "HF94700F84B8243E68991CC379CE8E7DE"}], "@display-inline": "no-display-inline", "#text": "\n\t\t\t", "@id": "HD949A4D34C544FBE8C6C86B8422B99A7"}], "#text": "\n\t\t", "@id": "HAD87D55459044704810FC2D7AD4AD883"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-03-13"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 S2126 IS: Regenerative Medicine Promotion Act of 2014"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. Senate"}, "#text": "\n"}, "#text": "\n"}}}